(1)(a) Repealed.
(b)Infants born in the state of Colorado shall be tested for the following
conditions: Phenylketonuria, hypothyroidism, abnormal hemoglobins, galactosemia,
cystic fibrosis, biotinidase deficiency, and such other conditions as the state board
may determine meet the criteria set forth in subsection (1)(c) of this section. The
birthing facility where the infant is born shall forward all appropriate specimens to
the laboratory operated or designated by the department. The physician, nurse,
midwife, or other health professional attending a birth outside a birthing facility is
responsible for collecting and forwarding the specimens. The laboratory shall
forward the results of the testing directly to the physician, primary care provider, or
other health-care provider
Free access — add to your briefcase to read the full text and ask questions with AI
(1) (a) Repealed.
(b) Infants born in the state of Colorado shall be tested for the following
conditions: Phenylketonuria, hypothyroidism, abnormal hemoglobins, galactosemia,
cystic fibrosis, biotinidase deficiency, and such other conditions as the state board
may determine meet the criteria set forth in subsection (1)(c) of this section. The
birthing facility where the infant is born shall forward all appropriate specimens to
the laboratory operated or designated by the department. The physician, nurse,
midwife, or other health professional attending a birth outside a birthing facility is
responsible for collecting and forwarding the specimens. The laboratory shall
forward the results of the testing directly to the physician, primary care provider, or
other health-care provider as needed for the provision of such information to the
parent, parents, or guardians of the child. The results of any testing or follow-up
testing pursuant to section 25-4-1004.5 may be sent to the immunization tracking
system authorized by section 25-4-2403 and accessed by the physician or other
primary health-care provider. The state board may discontinue testing for any
condition listed in this subsection (1)(b) if, upon consideration of criteria set forth in
subsection (1)(c) of this section, the state board finds that the public health is better
served by not testing infants for that condition. Testing under this subsection (1)(b)
is not required if the parent or legal guardian objects.
(c) The state board shall use the following criteria to determine whether to
test infants for conditions that are not specifically enumerated in this subsection
(1):
(I) The condition for which the test is designed presents a significant danger
to the health of the infant or his family and is amenable to treatment;
(II) The incidence of the condition is sufficiently high to warrant screening;
(III) The test meets commonly accepted clinical standards of reliability, as
demonstrated through research or use in another state or jurisdiction; and
(IV) The cost-benefit consequences of screening are acceptable within the
context of the total newborn screening program.
(1.5) If the department deems that new conditions for which an infant must
be tested should be added, the department shall report the added conditions to the
general assembly during its presentation in accordance with the State
Measurement for Accountable, Responsive, and Transparent (SMART) Government
Act, part 2 of article 7 of title 2. The department shall also notify the joint budget
committee and the health and human services committee of the senate and the
health, insurance, and environment committee and the public health care and
human services committee of the house of representatives, or their successor
committees, within sixty days after the department recommends a new condition
and include the added conditions in the department's annual budget request
submitted to the general assembly each November 1.
(2) The executive director of the department of public health and
environment shall assess a fee that is sufficient to cover the direct and indirect
costs of the testing required by this section and to accomplish the other purposes
of this part 10. Birthing facilities may assess a reasonable fee to be charged the
parent, parents, or guardians of the infant to cover the costs of handling the
specimens, the reimbursement of laboratory costs, and the costs of providing other
services, including the connection of follow-up services and care to infants
identified as at risk through screening, necessary to implement the purposes of this
part 10.
(3) The state board shall promulgate rules concerning the requirements of
the newborn screening program for genetic and metabolic disorders, including:
(a) In addition to those conditions listed in subsection (1)(b) of this section,
any other conditions for which testing must occur;
(b) Obtaining samples or specimens from newborn infants required for the
tests prescribed by the state board; and
(c) The handling and delivery of samples or specimens for testing and
examination.